Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Revenues from Contract with Customers - Additional Information (Details)

v3.22.1
Revenues from Contract with Customers - Additional Information (Details)
€ in Thousands
 12 Months Ended
Dec. 31, 2021
EUR (€)
Segment
Dec. 31, 2020
EUR (€)
Dec. 31, 2019
EUR (€)
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Number of segments | Segment 2    
Revenue from contracts with customers € 843,920 € 662,037 € 536,539
Increase in revenue from contract with customer € 181,883 € 125,498  
Percentage of revenues increased 27.50% 23.40%  
Percentage of revenue increased excluding USD negative impact 28.20%    
Revenue that was included in contract liability € 11,736 € 19,765 17,218
Transaction price allocated to remaining performance obligations € 74,996 56,417  
Description of entity satisfies its performance obligation the Group will recognize this revenue as projects are completed, which is expected to occur over the next 12–18 months.    
Goods and Services Transferred Over Time      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers € 140,726 69,830 47,814
APAC      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers € 117,747 67,135 55,522
Percentage of revenues increased 75.40%    
North America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers € 206,961 174,919 132,435
Percentage of revenues increased 18.30%    
South America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers € 25,738 21,844 25,758
Percentage of revenues increased 17.80%    
EMEA      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers € 493,474 398,139 322,824
Percentage of revenues increased 23.90%    
High-Value Solutions      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers € 207,815 146,332 90,700
Other Containment and Delivery Solutions      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 486,223 418,599 364,341
Revenues from Engineering      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 149,882 97,106 81,498
Biopharmaceutical and Diagnostic Solutions      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 694,038 564,931 455,041
Biopharmaceutical and Diagnostic Solutions | Goods and Services Transferred Over Time      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 26,321 11,142  
Biopharmaceutical and Diagnostic Solutions | APAC      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 79,463 54,433 41,129
Biopharmaceutical and Diagnostic Solutions | North America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 175,231 151,418 119,054
Biopharmaceutical and Diagnostic Solutions | South America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 23,855 20,516 24,519
Biopharmaceutical and Diagnostic Solutions | EMEA      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 415,489 338,564 270,339
Biopharmaceutical and Diagnostic Solutions | High-Value Solutions      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 207,815 146,332 90,700
Increase in revenue from contract with customer € 61,483 € 55,632  
Percentage of revenues increased 42.00% 61.30%  
Biopharmaceutical and Diagnostic Solutions | Other Containment and Delivery Solutions      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers € 486,223 € 418,599 364,341
Increase in revenue from contract with customer € 67,624 € 54,258  
Percentage of revenues increased 16.20% 14.90%  
Engineering      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers € 149,882 € 97,106 81,498
Engineering | Goods and Services Transferred Over Time      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 114,405 58,689 47,814
Increase in revenue from contract with customer € 55,716    
Percentage of revenues increased 94.90%    
Engineering | APAC      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers € 38,284 12,702 14,393
Engineering | North America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 31,730 23,501 13,381
Engineering | South America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 1,883 1,328 1,239
Engineering | EMEA      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 77,985 59,575 52,485
Engineering | Revenues from Engineering      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenue from contracts with customers 149,882 97,106 € 81,498
Increase in revenue from contract with customer € 52,776 € 15,608  
Percentage of revenues increased 54.30% 19.10%  
In-Vitro Diagnostic Business | Goods and Services Transferred Over Time      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Increase in revenue from contract with customer € 15,179    
Percentage of revenues increased 136.20%